News

Enterprises in France are facing competing pressures, prompting them to reassess their public cloud investments to balance the need for AI-driven innovation and cost optimization, according to a

Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the second quarter of fiscal 2025 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, February 20, 2025.

Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the second quarter of fiscal 2025 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, February 20, 2025.

Copart, Inc. (NASDAQ: CPRT) announced today that it will release earnings for the second quarter of fiscal 2025 after 4:00 p.m. Eastern Time (3:00 p.m. Central) on Thursday, February 20, 2025.

QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care settings, clinical labs and

Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold,” the “Company,” “we,” “us,” or “our”) reports net income of $332.0 million, or $5.04 per share, for the year ended

Martin Midstream Partners L.P. (Nasdaq: MMLP) (“MMLP” or the “Partnership”) today announced its financial results for the fourth quarter and full year ended December 31, 2024.

Bob Bondurant

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the full year and fourth quarter ended December 31, 2024.

CEO Remarks

“Ventas delivered strong financial

CI Financial Corp. (“CI” or the “Corporation”) (TSX:CIX) announced that at the special meeting of shareholders held earlier today, an overwhelming majority of CI shareholders voted in favour of the

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS^® (brentuximab vedotin) in

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS^® (brentuximab vedotin) in

Regulatory News:

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of a presentation by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial

Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm, said today it has recognized 50 technology and business services providers for their

Eastman Chemical Company (NYSE:EMN):

Industrial Select Conference

Mark Costa, Board Chair and Chief Executive Officer, Eastman Chemical Company (NYSE:EMN), will address the Barclays 42^nd

Jim Vena, chief executive officer, Jennifer Hamann, executive vice president and chief financial officer, and Kenny Rocker, executive vice president – Marketing & Sales, of Union Pacific

SERVICENOW FEDERAL FORUM – ServiceNow (NYSE: NOW), the AI platform for business transformation, today launched the new Government Transformation Suite to increase visibility, accelerate ROI, and

(NASDAQ: RDFN) — Today’s average home listing is selling for under its asking price, and taking a long time to sell, according to a new report from Redfin (redfin.com), the technology-powered real

Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended December 31, 2024.

Ted Wahl, Chief Executive Officer, stated, “2024 was a transitional year for

CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending February 28, 2025 in respect of the CI ETFs. In all cases, the distribution will be

Exelon Corporation (Nasdaq: EXC) today reported its financial results for the fourth quarter and full year 2024.

"I am pleased to announce Exelon has delivered against our financial goals for